Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Viruses 14.2 (2022): 284.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
-
Reuter, Nina
Kropff, Barbara
Britt, William J.
Mach, Michael
Thomas, Marco
- DOI
-
10.3390/v14020284
- URN
-
urn:nbn:de:bvb:29-opus4-183720
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reuter, Nina
- Kropff, Barbara
- Britt, William J.
- Mach, Michael
- Thomas, Marco
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Advancing single cell and multiplex cloning strategies to identify broadly neutralizing antibodies targeting infectious pathogens
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Neutralizing antibodies as tools for structure-based vaccine design
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Advancing single cell and multiplex cloning strategies to identify broadly neutralizing antibodies targeting infectious pathogens
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Neutralizing antibodies as tools for structure-based vaccine design
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Advancing single cell and multiplex cloning strategies to identify broadly neutralizing antibodies targeting infectious pathogens
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Neutralizing antibodies as tools for structure-based vaccine design